Characterization of TAE684 as a potent LRRK2 kinase inhibitor. (2012)
Attributed to:
A systematic investigation into the pathogenesis and course of Parkinson's syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bmcl.2012.01.084
PubMed Identifier: 22335897
Publication URI: http://europepmc.org/abstract/MED/22335897
Type: Journal Article/Review
Volume: 22
Parent Publication: Bioorganic & medicinal chemistry letters
Issue: 5
ISSN: 0960-894X